Advertise on podcast: Clinical Capsules

Think every sinus infection needs an antibiotic? Think again. Updated guidelines for acute bacterial rhinosinusitis are sparking discussions about when antibiotics are truly warranted—and pharmacy teams play a key role in helping guide practice.  In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, explains new recommendations for “watchful waiting,” when to initiate antibiotics, supportive care measures to try, and more. You’ll also hear practical pearls on first-line therapy, dosing strategies for amoxicillin and amoxicillin/clavulanate, and safe alternatives for penicillin-allergic patients. Plus, Gina shares tips for counseling patients and reducing antibiotic resistance while improving outcomes. This is an excerpt from our December 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Keep A “Watch and Wait” Approach for Acute SinusitisChart: Managing Beta-Lactam AllergiesChart: Antibiotic Therapy: When Are Shorter Courses Better?Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Vaping is more popular than ever, especially among young adults, and pharmacy teams are in a prime position to guide patients toward cessation. In this episode, TRC Healthcare editor, Gina Corley, PharmD, breaks down the health risks of vaping and shares unique barriers to vaping cessation. She also discusses how proven smoking cessation strategies (varenicline, nicotine replacement therapy, and bupropion) may work to help patients quit vaping. Plus, you’ll hear about counseling points and free resources to support patients in their quit journey. This is an excerpt from our September 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Help Patients Send Their Vaping Habits Up in SmokeChart: Smoking Cessation Drug TherapyFAQ: E-Cigarettes and VapingPodcast: Medication Talk - Smoking and Vaping Cessation Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

RSV prevention is more important than ever, and pharmacy teams are on the front lines. In this episode, TRC Healthcare Associate Editor, Vickie Danaher, PharmD, reviews who should receive RSV vaccines, recent changes to age and risk-based recommendations, and how monoclonal antibodies protect infants and high-risk children.  You’ll also hear practical tips on the best time to vaccinate patients, co-administration with other vaccines, product nuances, and safety considerations to help confidently guide patients through RSV prevention this season. This is an excerpt from our October 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Stay Current on RSV Immunization GuidanceChart: RSV VaccinesChart: Preventing RSVChart: RSV Monoclonal AntibodiesDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, Rachel Cole, PharmD, walks us through the evolving landscape of restless leg syndrome management, highlighting why dopamine agonists are no longer first-line therapy and what that means for clinical practice.  You’ll learn about the importance of checking for iron deficiency, practical non-drug interventions, and alternative medications like gabapentin and pregabalin.  Rachel shares actionable tips for educating patients, managing tricky cases, and staying up to date with the latest sleep medicine guidelines, so you can take confident steps forward in caring for patients with RLS. This is an excerpt from our July 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Stay in Step With Treatments for Restless Legs SyndromeChart: Oral Iron Comparison and Practical Considerations for UseDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, Rachel Cole, PharmD, explores the evolving landscape of medications for HIV pre-exposure prophylaxis (PrEP), spotlighting lenacapavir (Yeztugo)—a newly approved long-acting injectable option given just twice yearly.  She walks through how it compares to oral therapies like Truvada and Descovy, plus other injectables such as cabotegravir. Rachel also offers practical guidance on identifying candidates for HIV PrEP, navigating lab requirements, and managing side effects.  You’ll also hear strategies to help patients overcome cost barriers, improve adherence, and understand the importance of regular follow-up.  Whether you’re supporting patients at the pharmacy counter or staying current on HIV prevention, this episode delivers timely insights for pharmacy teams and other healthcare professionals. This is an excerpt from our September 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Add Lenacapavir to Your List of PrEP RecommendationsChecklist: HIV Pre-Exposure Prophylaxis (PrEP)New Drug Graphic: Lenacapavir (Yeztugo)Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and MoreDon’t miss out! Subscribe today to stay ahead.  10% off a new or upgraded subscription with code cc1025 at checkout. 🎓 Student free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, dives into the 2025/2026 flu vaccine season with a clear overview of what’s new and what remains consistent. From updated vaccine strain compositions and preferred products for older adults to thimerosal-free recommendations and egg allergy guidance, this episode equips you with the latest evidence-based insights. She also tackles common patient questions, discusses coadministration with COVID-19 and RSV vaccines, and shares practical strategies to boost vaccine confidence and avoid administration errors. Whether you're prepping for flu season or answering tough questions at the pharmacy counter, this episode has you covered. This is an excerpt from our September 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Answer Questions About 2025-2026 Flu VaccinesChart: Flu Vaccines for 2025-26 (United States)FAQ: Communicating About Flu VaccinationArticle: Stay Current on RSV Immunization GuidanceArticle: Clarify Facts About COVID-19 Vaccines for 2025-202610% off a new or upgraded subscription with code cc1025 at checkout. 🎓 Student free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses how pharmacists and pharmacy technicians play a vital role in ensuring access to buprenorphine for opioid use disorder treatment. She’ll explore approaches to addressing dispensing barriers, inventory management strategies, and the importance of recognizing opioid use disorder as a chronic condition requiring appropriate long-term care.  This is an excerpt from our March 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Break Down Barriers to Dispensing Buprenorphine for OUDFAQ: Management of Opioid Use DisorderGraphic: Opioid Reversal Agents Quick Start GuideCourse: Substance Use Disorders and Pain Management: MATE Act TrainingDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Rachel Cole, PharmD, evaluates 3 new migraine treatments: Atzumi, Brekiya, and Symbravo. She'll explain their dosing techniques and how they compare to existing therapies, while providing practical guidance on clinical considerations and cost-effective alternatives for acute migraine management. This is an excerpt from our August 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Stay Up to Date on “New” Migraine MedsChart: Drugs for Acute MigraineChart: Migraine ProphylaxisFAQ: Medication Overuse HeadacheDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Rachel Cole, PharmD, unpacks the updated recommendations for H. pylori management, spotlighting why bismuth quadruple therapy is now front and center and how to navigate antibiotic resistance and patient-specific factors. You’ll come away with actionable pearls on regimen selection, adherence strategies, and which drug interactions to watch for.  This is an excerpt from our February 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Stay Current on H. pylori Treatment GuidanceChart: Helicobacter pylori: From Diagnosis to EradicationGraphic: Helicobacter pylori Treatment SummaryDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, digs into Suzetrigine—brand name Journavx—the first non-opioid analgesic approved in over two decades.  You’ll hear how it works, how it compares to hydrocodone/acetaminophen, and why it might be a game-changer for patients at risk of opioid misuse. We’ll also unpack limitations in the clinical trials, cost concerns, dosing nuances, and key drug interactions to watch for. Plus, we’ll share tips for counseling patients and navigating formulary decisions, especially if your site participates in the manufacturer’s pilot program.  Don’t miss our quick skim graphic and comparison resource to help you make informed decisions. This is an excerpt from our April 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Explain How Suzetrigine Stacks Up for Acute PainGraphic: New Drug: Suzetrigine (Journavx)Resource: Analgesics for Acute Pain in AdultsDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code cc1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses recently approved drug formulations that bring fresh options—and new challenges—to the pharmacy counter.  From Arbli, the first ready-to-use losartan suspension, to Emrosi, a low-dose minocycline for rosacea, and Opipza, an oral film version of aripiprazole, we’ll walk through what makes each product unique and what pharmacy teams should watch for. We also cover HemiClor, a 12.5 mg chlorthalidone tablet that may help patients avoid splitting unscored tabs, Neffy, a needle-free epinephrine nasal spray now available in a pediatric strength, and wrap up with biosimilar updates on Merilog and Omlyclo.  This is an excerpt from our June 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Watch for New Twists to Older MedicationsChart: Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsChart: Treatments for RosaceaChart: Comparison of Commonly Used DiureticsChart: Comparison of Atypical AntipsychoticsChart: Emergency Epinephrine DevicesChart: Facts About BiosimilarsUse code cc1025 at checkout for 10% off a new subscription. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS unpacks the newly approved use of tirzepatide (Zepbound) for obstructive sleep apnea (OSA)—a first-in-class pharmacologic option for a condition long managed with devices and lifestyle changes. You’ll hear a concise review of sleep apnea pathophysiology, how tirzepatide works to reduce airway obstruction, and what the latest clinical trials reveal about its efficacy and safety. Plus,  you’ll get practical pharmacy-focused insights on side effect management, payer considerations, and how to avoid duplicate GLP-1 therapy.  This is an excerpt from our April 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Watch for Tirzepatide for Sleep ApneaChart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison ChartDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. **** GLP-1 Essentials from TRC Healthcare – Now Available Master the essentials of GLP-1 therapy with this focused GLP-1 agonists CE bundle. Get 4 hours of CE plus clinical tools to help you prescribe, titrate, switch therapies, and support patients confidently. Courses include: GLP-1 Agonists: Understanding the Essentials (1.5 hours)GLP-1 Agonists: Supporting Success with Nutrition and Lifestyle Considerations (1 hour)GLP-1 Agonists: Optimizing Therapy Across Clinical Scenarios (1.5 hours)GLP-1 Agonists: Pipeline and Emerging Therapies (no CE credit; regular updates planned)Now included with Pharmacist’s Letter Platinum and Diamond subscriptions, or available as a standalone CE experience. **** Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, guides listeners through the evolving landscape of biosimilars, highlighting their increasing presence in pharmacy practice and their critical distinctions from traditional generics. She explains the science behind biologics, the FDA’s rigorous approval process for biosimilars, and the nuances of interchangeability. With examples of biosimilars for Stelara, Humira, and Prolia, Vickie illustrates how pharmacists can confidently counsel patients, verify product details, and stay compliant with state laws.  Whether you're stocking shelves or answering patient questions, this episode equips you with the knowledge to handle biosimilars with confidence, precision, and care. This is an excerpt from our January 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Brush Up on BiosimilarsFAQ: Facts About BiosimilarsDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Rachel Cole, PharmD, delves into the debate about whether newer medications for Type 2 diabetes, including SGLT-2 inhibitors or GLP-1 agonists, should be used first-line instead of metformin. She examines the benefitsand drawbacks of these newer medications, including their cardiovascular and kidney benefits, side effects, and costs. This is an excerpt from our March 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Stay Current on Med Recommendations for DiabetesAlgorithm: Stepwise Treatment of Type 2 DiabetesChart: Diabetes Medications: Cardiovascular and Kidney ImpactResource Hub: DiabetesDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

In this episode, TRC Healthcare editor, Don Weinberger, PharmD, PMSP, explores how to avoid medication mishaps with pet prescriptions. Learn about common pitfalls, species-specific risks, and best practices for pharmacists and technicians. This is an excerpt from our December 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Don’t Chase Your Tail With Pet RxsFAQ: Med Considerations for Cats and Dogs Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.  Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Send us a text Email us: [email protected]. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.